Thousands of Ranker users have spoken, naming Ana de Armas the most beautiful actress of 2025 in a fan driven ranking that has the internet debating.

Thousands of Ranker users have spoken, naming Ana de Armas the most beautiful actress of 2025 in a fan driven ranking that has the internet debating.

From Knives Out to Blonde, her rise has been impossible to ignore, and this vote places her ahead of some of Hollywood’s biggest icons, including Margot Robbie and Scarlett Johansson. Love it or not, it reflects just how strong her cultural presence has become.

The full Top 10 most beautiful actresses of 2025 according to Ranker:
 10. Minka Kelly
 11. Alexandra Daddario
 12. Salma Hayek
 13. Victoria Justice
 14. Lily Collins
 15. Jessica Alba
 16. Sydney Sweeney
 17. Scarlett Johansson
 18. Margot Robbie
 19. Ana de Armas

Did Ranker get it right putting Ana de Armas at number one?

Comments

Post a Comment

Thundergist Entertainment
comment here Now

Popular posts from this blog

Unveils Tracklist, Phyno To Release Debut Album

Image
ndigenous Nigerian rapper,  Phyno,  has plotted the release of his debut album and has unveiled the tracklist and title of the anticipated LP. Titled  “No Guts No Glory” ; the album is a 19-track effort, which boasts major production from Phyno and Major Bangz, not forgetting mouth-watering collaborations from Runtown, Omawumi, Olamide, Ice Prince, P-Square and more. Phyno  is popular for his hit songs, ‘Ghost Mode’ with Olamide, and ‘Man Of The Year’ which was released last year.
Read more

The CDC has terminated its long-standing "universal" recommendation that every newborn receive a hepatitis B vaccine dose within 24 hours of birth, marking a significant shift in U.S. childhood immunization policy.

Image
The CDC has terminated its long-standing "universal" recommendation that every newborn receive a hepatitis B vaccine dose within 24 hours of birth, marking a significant shift in U.S. childhood immunization policy.  Under the updated guidance, the birth dose is still recommended immediately for babies whose mothers are hepatitis B–positive or whose hepatitis B status is unknown.  For infants born to mothers who test negative, the CDC now recommends "individual-based decision-making"—meaning parents and clinicians decide together whether to give the shot at birth or start the series later. If the birth dose is deferred, the CDC suggests beginning the series no earlier than 2 months of age.  The change follows an 8–3 vote by ACIP on December 5, 2025, and the CDC adopted the recommendation on December 16, 2025.  Pediatric and public health groups, including the American Academy of Pediatrics, have criticized the move, warning it could weaken a proven "safety net...
Read more